Sorafenib is a multikinase inhibitor targeting several serine/threonine and receptor tyrosine kinases. The drug is marketed as Nexavar and is used in the treatment of renal cell carcinoma (Kidney cancer). It is also being studied as treatment in other types of cancer.
Related categories 1
Official site for obtaining this oral multiple kinase inhibitor for the treatment of patients with liver or kidney cancer. Information provided on how to obtain drug.
Rxlist: Nexavar (Sorafenib)
Provides medication description and drug information including side effects, interactions and patient labeling.
Last update:April 20, 2008 at 0:18:01 UTC